Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Fujian Yango $175 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $175 million principal amount of 11.875% senior notes due 2023 by Yango (Cayman) Investment…
Intercontinental Exchange $894.4 million block trade
Davis Polk advised the underwriter in connection with a block trade of 9,180,569 shares of common stock of Intercontinental Exchange, Inc. by a selling shareholder. The shares sold in…
RemeGen HK$4 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule 144A…
Novo Nordisk acquisition of Emisphere Technologies
Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc. and related Eligen SNAC royalty stream obligations owed to MHR Fund Management LLC,…
Back to top